'Yo-Yo' Dieting Won't Raise Cancer Risk, Study Finds

TUESDAY, Aug. 4, 2015 (HealthDay News) -- "Yo-yo dieting" does not increase cancer risk, a new study suggests.

Combo Rx May Boost Ovarian Cancer Outcomes, But Too Few Get It: Study

MONDAY, Aug. 3, 2015 (HealthDay News) -- Chemotherapy delivered directly into the abdomen significantly improves survival among women with advanced ovarian cancer, a new study finds.

Urine Test Might Find Pancreatic Cancer Early, Study Suggests

MONDAY, Aug. 3, 2015 (HealthDay News) -- Scientists report that they have developed a urine test that may detect pancreatic cancer at an early stage.

Do Sporty Teen Girls Live Longer, Healthier Lives?

FRIDAY, July 31, 2015 (HealthDay News) -- Women who exercised or played sports as teens have a lower risk of premature death from cancer or any other cause much later in life, new research shows.

Scientists Suggest New Way to Predict Lung Cancer Risk

WEDNESDAY, July 29, 2015 (HealthDay News) -- Scientists may some day predict lung cancer risk by examining the telomeres that protect your DNA.

After Breast Cancer, Many in Appalachia Say No to Lifesaving Drugs

MONDAY, July 27, 2015 (HealthDay News) -- About one-third of breast cancer survivors in the Appalachian region of the United States do not take potentially lifesaving drugs, even though their drugs are covered by insurance, a new study finds.

Many Young Cancer Patients Unaware of Fertility Preservation Options

MONDAY, July 27, 2015 (HealthDay News) -- Many young cancer patients -- especially females -- have limited awareness about options to preserve their fertility, a new study shows.

1 in 3 Colon Cancers in Young People Has Genetic Link

FRIDAY, July 24, 2015 (HealthDay News) -- More than a third of colon cancers diagnosed in younger patients are caused by inherited gene mutations, a new study finds.

New Skin Cancer Drug Approved by FDA

FRIDAY, July 24, 2015 (HealthDay News) -- A new drug to treat the most common form of skin cancer has been approved by the U.S. Food and Drug Administration.

Odomzo Approved for Recurring Basal Cell Carcinoma

FRIDAY, July 24, 2015 (HealthDay News) -- Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat basal cell carcinoma skin cancer that has returned despite surgery or radiation.